Carmustine

GPTKB entity

Statements (54)
Predicate Object
gptkbp:instanceOf gptkb:chemical_compound
gptkb:nitrosourea
antineoplastic agent
gptkbp:approvalYear 1977
gptkbp:approvedBy gptkb:FDA
gptkbp:aroma none
gptkbp:ATCCode L01AD01
gptkbp:brand gptkb:BiCNU
gptkb:Gliadel
gptkbp:CASNumber 154-93-8
gptkbp:color yellow
gptkbp:discoveredBy gptkb:National_Cancer_Institute
gptkbp:drugClass antineoplastic agent
gptkbp:eliminationHalfLife 15-30 minutes
gptkbp:excretion gptkb:kidney
gptkbp:hasInChIKey XQNWGFRJXWCOJM-UHFFFAOYSA-N
gptkbp:hasMolecularFormula C5H9Cl2N3O2
gptkbp:hasSMILES C(CN(CCCl)C(=O)N(CCCl)N=O)Cl
gptkbp:hasStorageRequirement refrigerated
gptkbp:hasUNII U68V09E7SZ
https://www.w3.org/2000/01/rdf-schema#label Carmustine
gptkbp:isSolubleIn gptkb:beer
gptkb:water
gptkb:chloroform
lipids
gptkbp:IUPACName 1,3-bis(2-chloroethyl)-1-nitrosourea
gptkbp:KEGGID D00297
gptkbp:legalStatus prescription only
gptkbp:mechanismOfAction alkylates DNA and RNA
gptkbp:meltingPoint 30-32°C
gptkbp:metabolism liver
gptkbp:molecularWeight 214.05 g/mol
gptkbp:pregnancyCategory D
gptkbp:PubChem_CID 2478
2578
CHEMBL1387
DB00262
gptkbp:routeOfAdministration intravenous
implant (wafer)
gptkbp:sideEffect nausea
vomiting
liver toxicity
pulmonary toxicity
bone marrow suppression
kidney toxicity
gptkbp:usedForTreatmentOf leukemia
melanoma
multiple myeloma
Hodgkin lymphoma
brain tumors
gptkbp:WHOModelListOfEssentialMedicines true
gptkbp:bfsParent gptkb:BCNU
gptkb:Sigma-Tau_Pharmaceuticals
gptkbp:bfsLayer 8